SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
SANUWAVE Health, Inc.NASDAQ: SNWV
Operating Margin · Q1 FY2026 · quarter ended Mar 2026
Operating margin narrows to -11.7%
Operating margin was -11.7% in Q1 FY2026, down 22.2 pp from a year earlier. On a trailing-twelve-month basis it was 6.4%, down 14.2 pp year over year. Over 3 fiscal years it widened by 64.7 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
What to watch
Whether operating margin reaches the consensus estimate from 1 analysts of -28.0% for the fiscal year ending Dec 2026, down from 11.2% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -11.7%-16.4 pp QoQ
- Last fiscal yearDec 2025
- 11.2%-5.4 pp YoY
- LTMMar 2026
- 6.4%-14.2 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 11.2%
- Year-over-year change
- -5.4pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.2% | -5.4pp |
| FY2024 | 2024-12-31 | 16.6% | +19.2pp |
| FY2023 | 2023-12-31 | -2.6% | +50.8pp |
| FY2022 | 2022-12-31 | -53.5% | +55.2pp |
| FY2021 | 2021-12-31 | -108.7% | — |
Operating Margin vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 operating margin of 6.4% is the highest of the 10 companies compared; the peer median is -82.7%.
- Its year-over-year change of -14.2 pp is the 9th highest of 10, against a peer median of +36.4 pp.
- Over three fiscal years its change of +64.7 pp compares with a peer median of +83.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 6.4% | -14.2 pp | +64.7 pp | |
| LTM Mar 2026 | -8.8% | +1.2 pp | +13.9 pp | |
| LTM Mar 2026 | -44.8% | +18.8 pp | +69.7 pp | |
| LTM Mar 2026 | -52.5% | +61.2 pp | +32.5 pp | |
| LTM Mar 2026 | -56.9% | +23.6 pp | +83.7 pp | |
| LTM Mar 2026 | -82.7% | -35.0 pp | +19.6 pp | |
| LTM Mar 2026 | -196.6% | +3143.9 pp | +1620.5 pp | |
| LTM Mar 2026 | -213.0% | +83.0 pp | +224.9 pp | |
| LTM Mar 2026 | -286.2% | +128.2 pp | +343.6 pp | |
| LTM Dec 2025 | -466.2% | +36.4 pp | +812.8 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding SNWV) | -82.7% | +36.4 pp | +83.7 pp | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.01M | 16.74M | 20.4M | 32.63M | 44.05M |
| Cost of Revenue | 4.99M | 4.33M | 6.04M | 8.08M | 10.08M |
| Gross Profit | 8.02M | 12.41M | 14.36M | 24.55M | 33.97M |
| Gross Margin | 61.7% | 74.1% | 70.4% | 75.2% | 77.1% |
| Research & Development | 1.1M | 567K | 579K | 673K | 1.35M |
| Selling, General & Admin | 20.28M | 20.03M | 13.57M | 17.67M | 26.79M |
| Operating Expenses | 22.17M | 21.36M | 14.9M | 19.13M | 29.02M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| EBITDA | (18.9M) | 4.79M | (9.15M) | (16.56M) | 19.43M |
| EBITDA Margin | -145.3% | 28.6% | -44.9% | -50.8% | 44.1% |
| Operating Income | (14.14M) | (8.95M) | (540K) | 5.42M | 4.95M |
| Operating Margin | -108.7% | -53.5% | -2.6% | 16.6% | 11.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.1M | 14.13M | 15.62M | 13.64M | 6.25M |
| Other Income / Expenses | (13.09M) | (1.34M) | (25.26M) | (36.76M) | 6.95M |
| Income Before Tax | (27.23M) | (10.29M) | (25.8M) | (31.35M) | 11.9M |
| Pre-Tax Margin | -209.3% | -61.5% | -126.5% | -96.1% | 27.0% |
| Income Tax Expense | 28K | 2K | 4K | 27K | 86K |
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Net Margin | -209.5% | -61.5% | -126.5% | -96.1% | 26.8% |
| EPS (Basic) | (19.72) | (7.02) | (12.19) | (7.03) | 1.38 |
| EPS (Diluted) | (19.72) | (7.02) | (12.19) | (7.03) | 0.41 |
| Weighted Avg Shares | 1.38M | 1.47M | 2.12M | 4.46M | 8.56M |
| Weighted Avg Shares (Diluted) | 1.38M | 1.47M | 2.12M | 4.46M | 9.08M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.